Quiet on the insider front: nobody at Kiora Pharmaceuticals Inc bought or sold KPRX shares on the open market this past year.
No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters. 22 investment managers listed KPRX in their latest 13F filings (Q2 2026); more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Stengone Carmine N. | Director | Buy | 1,250 | $3.68 | $5K | SEC |
| Sep 11, 2024 | Shapiro Aron | Director | Buy | 3,000 | $3.60 | $11K | SEC |
| Aug 20, 2024 | Walters-Hoffert Lisa | Director | Buy | 1,250 | $3.86 | $5K | SEC |
| Aug 19, 2024 | TYLE PRAVEEN | Director | Buy | 5,000 | $3.96 | $20K | SEC |
| Aug 15, 2024 | Tosca Melissa | CFO | Buy | 2,000 | $3.21 | $6K | SEC |
| Jun 14, 2024 | Tosca Melissa | Executive Officer | Buy | 100 | $5.25 | $525 | SEC |
| Jun 14, 2024 | Daniels Eric Joseph | Executive Officer | Buy | 1,431 | $5.29 | $8K | SEC |
| Jun 13, 2024 | Parsons Erin | Director | Buy | 5,260 | $4.88 | $26K | SEC |
| Jun 13, 2024 | Strem Brian M. | CEO | Buy | 3,000 | $5.00 | $15K | SEC |
There were no open-market insider trades in KPRX in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
22 investment managers reported holding KPRX in SEC Form 13F filings for Q2 2026.
No congressional trades in KPRX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).